<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV)-related non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (HIV-NHL) are <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> and associated with distinct molecular pathways </plain></SENT>
<SENT sid="1" pm="."><plain>Analysis of immunoglobulin variable genes (IGV) may provide insights into the pathogenesis and histogenesis of HIV-NHL </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN AND METHODS: IGV rearrangements were amplified from genomic DNA by polymerase chain reaction and directly sequenced in 87 cases of HIV-NHL (17 Burkitt/Burkitt-like <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 38 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, and 32 primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphomas</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A skewed IGHV repertoire in specific HIV-NHL clinico-pathological categories was observed </plain></SENT>
<SENT sid="4" pm="."><plain>Systemic HIV-diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> displayed underrepresentation of the IGHV3 family (11/38, 28.9%; p=0.0047) and, in particular, of the IGHV3-23 gene (0/38; p&lt;0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>These same cases were also characterized by significant overrepresentation of the IGHV4 family (18/38; 47.4%; p=0.0044) and, in particular, of the IGHV4-34 gene (10/38; 26.3%; p=0.003) </plain></SENT>
<SENT sid="6" pm="."><plain>HIV-primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphomas</z:hpo> displayed a preferential usage of IGLV6-57, with stereotyped B-cell receptor in two cases </plain></SENT>
<SENT sid="7" pm="."><plain>Somatic hypermutation of IGHV genes was detected in 81/87 (93.1%) HIV-NHL </plain></SENT>
<SENT sid="8" pm="."><plain>Unmutated cases were restricted to six HIV-primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> plasmacytoid <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>A mutational profile suggesting a tendency to maintain antigen binding and antigen selection was observed in more than 50% of the cases of IGV mutated HIV-NHL </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our data show evidence of a skewed IGHV repertoire in specific HIV-NHL categories and suggest B-cell receptor restriction in some HIV-primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> representation of IGHV genes in HIV-NHL may be related to specific pathways of antigen stimulation, or to differences in host's <z:hpo ids='HP_0002958'>immune dysregulation</z:hpo> and <z:hpo ids='HP_0002665'>lymphoma</z:hpo> histogenesis </plain></SENT>
</text></document>